Published in Immunology on April 01, 1978
Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32
Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two years. Clin Exp Immunol (1978) 1.07
Immune complexes in human diseases: a review. Am J Pathol (1980) 1.05
Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus. J Clin Invest (1980) 1.00
Inhibition of polymorphonuclear leukocyte chemiluminescence for detection of immune complexes in human sera. J Clin Invest (1980) 0.92
Isolation of circulating immune complexes by conglutinin and separation of antigen from dissociated complexes by immobilized protein A. Clin Exp Immunol (1981) 0.88
C1q enhancement of antibody-dependent granulocyte-mediated killing of nonphagocytosable targets in vitro. J Clin Invest (1988) 0.82
Correlation if circulating immune complexes and disease status in patients with leukaemia. Clin Exp Immunol (1981) 0.78
Binding of aggregated human gamma globulin by Raji cells: C1q will enhance only if it is dissociated from the C1 macromolecular complex. Immunology (1981) 0.77
Correlation of antibody to rheumatoid arthritis associated nuclear antigen and immune complexes to disease activity in patients with rheumatoid arthritis. Clin Exp Immunol (1983) 0.76
Characterization of antigen moiety of HBsAg in the complement fixing immune complexes of hepatitis B virus positive chronic active hepatitis. Clin Exp Immunol (1982) 0.75
Radioconglutinin-binding azssay for circulating immune complexes: a new method. Clin Exp Immunol (1980) 0.75
Interaction of human platelets with particle-adherent aggregated IgG: description of the experimental system and role of C1q and monomeric IgG. Clin Exp Immunol (1983) 0.75
A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL. Oncotarget (2015) 0.75
A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol (1966) 43.66
Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads. J Biol Chem (1970) 19.51
Receptors for complement of leukocytes. J Exp Med (1968) 11.57
Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst (1972) 10.15
Interaction of aggregated -globulin with B lymphocytes. J Exp Med (1972) 9.29
A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE. J Clin Pathol (1965) 8.64
The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest (1976) 8.06
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion. Immunology (1970) 6.89
Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. J Clin Invest (1974) 5.81
Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J Exp Med (1973) 4.46
CHARACTERIZATION OF A HUMAN MACROGLOBULIN. I. THE MOLECULAR WEIGHT OF ITS SUBUNIT. J Biol Chem (1965) 4.37
Effect of chemical and enzymatic radioiodination on in vitro human Clq activities. J Immunol (1973) 4.14
Detection and radioassay of soluble circulating immune complexes using guinea pig peritoneal exudate cells. Nature (1974) 3.37
C1q deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum. J Exp Med (1975) 3.21
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest (1970) 2.92
Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera. J Exp Med (1974) 2.51
Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism. J Exp Med (1974) 2.22
Chemical studies of Clq; a modulator of immunoglobulin biology. Biochem Biophys Res Commun (1971) 2.05
Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance. J Exp Med (1974) 1.91
C3b inactivator of man. 3. Further purification and production of antibody to C3b INA. J Immunol (1972) 1.64
Receptor for the fourth component of complement on human B lymphocytes and cultured human lymphoblastoid cells. J Exp Med (1974) 1.56
Clq inhibition of the interaction of collagen with human platelets. J Immunol (1976) 1.16
Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes. J Exp Med (1976) 1.01
C1q (c1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules. J Immunol (1976) 0.97
C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay. Clin Exp Immunol (1977) 0.96
Dynamic aspects of the interaction between antibodies and complement at the cell surface. Scand J Immunol (1974) 0.82
Complement components on the surface of normal human lymphocytes. Scand J Haematol (1974) 0.81
Rapid identification of monocytes in a mixed mononuclear cell preparation. J Immunol Methods (1977) 4.12
Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med (1976) 3.22
3H and 32P derivative methods for base composition and sequence analysis of RNA. Methods Enzymol (1980) 2.92
Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol (1989) 2.67
Basement zone antibodies in bullous pemphigoid. JAMA (1967) 2.66
Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome. Mayo Clin Proc (1973) 2.56
Rapid print-readout technique for sequencing of RNA's containing modified nucleotides. Nucleic Acids Res (1979) 2.54
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19
The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol (1968) 2.17
Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts. Cancer Res (1985) 2.16
Interaction of human rad51 recombination protein with single-stranded DNA binding protein, RPA. Nucleic Acids Res (1998) 2.08
Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci U S A (1984) 2.03
32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts. Carcinogenesis (1982) 1.95
32P-labeling test for DNA damage. Proc Natl Acad Sci U S A (1981) 1.89
Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor. J Clin Invest (1975) 1.86
Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med (1969) 1.83
Use of specific endonuclease cleavage in RNA sequencing. Nucleic Acids Res (1977) 1.77
Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor-cell differentiation. Int J Cancer (1972) 1.75
Primary tuberculosis of soft palate. Indian J Chest Dis Allied Sci (2001) 1.71
Role of the bursa of Fabricius in IgG and IgM production in the chicken: evidence for the role of a non-bursal site in the development of humoral immunity. J Immunol (1971) 1.65
Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum (1972) 1.56
Interaction of human recombination proteins Rad51 and Rad54. Nucleic Acids Res (1997) 1.54
Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) (1975) 1.54
Fat embolism syndrome. Lung India (2013) 1.53
Interaction of coagulation factor V and factor Va with platelets. J Biol Chem (1979) 1.53
Renal parenchymal malakoplakia. Br J Urol (1989) 1.51
Hypocomplementemia in rheumatoid arthritis. Am J Med (1973) 1.50
Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy. Curr Mol Med (2009) 1.50
Immunologic mechanisms in systemic vasculitis. Mayo Clin Proc (1976) 1.50
32P-postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents. Carcinogenesis (1984) 1.48
Structural analysis of nonradioactive RNA by postlabeling: the primary structure of baker's yeast tRNA Leu/CUA. Biochem Biophys Res Commun (1975) 1.41
Sequence analysis of nonradioactive RNA fragments by periodate-phosphatase digestion and chemical tritium labeling: characterization of large oligonucleotides and oligonucleotides containing modified nucleosides. Nucleic Acids Res (1974) 1.41
"LGB syndrome: is albumino-cytological dissociation essential for the diagnosis". J Assoc Physicians India (1994) 1.39
Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol (1971) 1.39
Immunofluorescence of cutaneous vasculitis associated with systemic disease. Arch Dermatol (1971) 1.38
Cutaneous vessel immune deposits in rheumatoid arthritis. Arthritis Rheum (1976) 1.38
Sequence studies on tRNAPhe from placenta: comparison with known sequences of tRNAPhe from other normal mammalian tissues. Biochem Biophys Res Commun (1975) 1.38
Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation (1994) 1.36
The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33
Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum (1982) 1.33
Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32
Oxidative DNA damage induced by activation of polychlorinated biphenyls (PCBs): implications for PCB-induced oxidative stress in breast cancer. Chem Res Toxicol (1996) 1.31
Role of vitamin D in pulmonary tuberculosis. J Assoc Physicians India (1984) 1.31
Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol (1982) 1.26
The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. J Lab Clin Med (1975) 1.24
Evidence for physiological functions of protein phosphatases in the heart: evaluation with okadaic acid. Am J Physiol (1993) 1.23
Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases. J Lab Clin Med (1977) 1.23
Use of specific endonuclease cleavage in RNA sequencing-an enzymic method for distinguishing between cytidine and uridine residues. Nucleic Acids Res (1977) 1.22
Immunologic tests in the diagnosis of rheumatic diseases. Part I. Bull Rheum Dis (1977) 1.22
Evaluation of metronidazole toxicity: a prospective study. Int J Clin Pharmacol Res (1999) 1.21
Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis. Ann Intern Med (1972) 1.21
Triplex-induced recombination in human cell-free extracts. Dependence on XPA and HsRad51. J Biol Chem (2001) 1.21
Circulating immune complexes in giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum (1980) 1.20
The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids. J Clin Invest (1973) 1.20
Human biomonitoring and the 32P-postlabeling assay. Carcinogenesis (1992) 1.19
Preciitating antibodies to mitochondrial antigens in patients with primary biliary cirrhosis. Clin Exp Immunol (1980) 1.19
The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation. Clin Immunol Immunopathol (1975) 1.17
Yeast tRNA Leu UAG. Purification, properties and determination of the nucleotide sequence by radioactive derivative methods. Eur J Biochem (1979) 1.15
Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol (1971) 1.15
T and B lymphocytes in contact and atopic dermatitis. Arch Dermatol (1976) 1.15
Negative complement immunofluorescence in pemphigus. J Invest Dermatol (1971) 1.15
Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart. Circ Res (1991) 1.15
Formation and removal of DNA adducts in rat liver treated with N-hydroxy derivatives of 2-acetylaminofluorene, 4-acetylaminobiphenyl, and 2-acetylaminophenanthrene. Carcinogenesis (1984) 1.15
Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Ann Intern Med (1972) 1.14
Oral pemphigus vulgaris. A report of ten cases. Arch Dermatol (1977) 1.14
Inherited deficiency of the fourth component of human complement. Immunodefic Rev (1988) 1.14
The nucleotide sequence of human tRNAGly (anticodon GCC). Nucleic Acids Res (1979) 1.13
Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res (1997) 1.12
Immunoglobulin classes of antibodies produced in the primary and secondary responses in man. Clin Exp Immunol (1969) 1.12
Hypocomplementemic urticarial vasculitis: association with chronic obstructive pulmonary disease. Mayo Clin Proc (1982) 1.12
Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region. Proc Natl Acad Sci U S A (1987) 1.11
Immune complexes and autoantibodies in silicosis. J Allergy Clin Immunol (1981) 1.11
Classical and alternate pathway activation of complement in pemphigus vulgaris lesions. J Invest Dermatol (1974) 1.11
An improved separation procedure for nucleoside monophosphates on polyethyleneimine-(PEI-)cellulose thin layers. Nucleic Acids Res (1976) 1.11
Pulmonary and extrapulmonary sarcoidosis in relation to circulating immune complexes: a quantification of immune complexes by two radioimmunoassays. Am Rev Respir Dis (1977) 1.10
Polymorphonuclear leukocyte inclusions and impaired bacterial killing in patients with Felty's syndrome. J Lab Clin Med (1976) 1.10
Cutaneous vascular immunofluorescence in rheumatoid arthritis. Correlation with circulating immune complexes and vasculitis. Am J Med (1980) 1.09
Pharmacology, toxicology and degradation of endosulfan A review. Toxicology (1980) 1.09
Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two years. Clin Exp Immunol (1978) 1.07
Childhood bullous dermatitis herpetiformis. Negative immunofluorescent tests. Arch Dermatol (1970) 1.07
Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients. Ann Rheum Dis (1976) 1.07
Immunoglobulin complexes in sera of patients with malignancy. Int J Cancer (1977) 1.06
High performance liquid chromatographic (HPLC) determination of centchroman in human serum and application to single-dose pharmacokinetics. Pharm Res (1989) 1.05
Experimental staphylococcal toxic epidermal necrolysis (TEN) in adult humans and mice. J Lab Clin Med (1974) 1.05
Primary tuberculosis of nose. Indian J Chest Dis Allied Sci (1997) 1.04
Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum (1979) 1.04
Impaired blastogenic response of lymphocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis. J Rheumatol (1976) 1.03
Erythema multiforme: direct immunofluorescence studies and detection of circulating immune complexes. J Invest Dermatol (1980) 1.03
Lupus erythematosus profundus with periorbital swelling and proptosis. J Am Acad Dermatol (1991) 1.02
Comparative study of NZB mice under germfree and conventional conditions. J Rheumatol (1975) 1.02